Prostein expression on circulating tumor cells as a prognostic marker in metastatic castration-resistant prostate cancer-Reference-Cited by-同舟云学术

Prostein expression on circulating tumor cells as a prognostic marker in metastatic castration-resistant prostate cancer

Published:2023-12-06 Issue: Volume: Page:
ISSN:1365-7852
Container-title:Prostate Cancer and Prostatic Diseases
language:en
Short-container-title:Prostate Cancer Prostatic Dis

Author:

Zhang Zhenchao,Luo Rui,Kelly William K.,Chen Joshua,Donahue Shane,Ip Kevan,Handley Nathan R.,Tester William J.,Tsang Miranda L.,Kim Felix J.,Myers Ronald,Lu-Yao Grace,Gu Jian,Lin Jianqing,Li Bingshan,Wang Chun^ORCID,Yang Hushan^ORCID

Funder

U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Urology,Oncology

Link

https://www.nature.com/articles/s41391-023-00762-3.pdf

Reference42 articles.

1. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17–48.

2. Lowrance WT, Murad MH, Oh WK, Jarrard DF, Resnick MJ, Cookson MS. Castration-resistant prostate cancer: AUA Guideline Amendment 2018. J Urol. 2018;200:1264–72.

3. Schaeffer E, Srinivas S, Antonarakis ES, Armstrong AJ, Bekelman JE, Cheng H, et al. NCCN guidelines insights: prostate cancer, Version 1.2021. J Natl Compr Cancer Netw. 2021;19:134–43.

4. Crocetto F, Russo G, Di Zazzo E, Pisapia P, Mirto BF, Palmieri A, et al. Liquid biopsy in prostate cancer management-current challenges and future perspectives. Cancers. 2022;14:3272.

5. Trujillo B, Wu A, Wetterskog D, Attard G. Blood-based liquid biopsies for prostate cancer: clinical opportunities and challenges. Br J Cancer. 2022;127:1394–402.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Managing Advanced Prostate Cancer: Breakthroughs in Hormone Therapy and Beyond;Transforming Prostate Cancer Care;2024